Antimicrobial resistance at a crossroads: the cost of inaction This Lancet paper examines the global cost of AMR, estimating there could be global gross domestic product loss of more than US$1 trillion annually beyond 2030 due to AMR. New blood test could help spot children at risk of serious illnesses, study finds Scientists say a new blood test that…
Ben KempSeptember 24, 2024










